DNTH peer analysis
Dianthus Therapeutics (DNTH) against its competitors: price, today's move, 1-year return and market value side by side.
DNTH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALMS Alumis | $6.03 | 3.08% | 31.95% | – |
| ANAB AnaptysBio | $45.80 | 0.48% | 27.22% | $1.37B |
| ARTV Artiva Biotherapeutics | $4.25 | 2.91% | 23.55% | – |
| CNTB Connect Biopharma | $0.73 | -6.25% | -56.58% | – |
| IMVT Immunovant | $29.10 | 2.50% | 23.31% | $6.01B |
| MLTX MoonLake | $11.60 | 7.41% | 9.54% | – |
| QTTB Q32 Bio | $9.25 | 4.52% | 287.03% | – |
| RNAC Cartesian Therapeutics | $6.78 | -0.59% | -11.60% | – |
| VERA Vera Therapeutics | $30.37 | 0.76% | 26.02% | – |
| DNTH Dianthus Therapeutics | $88.00 | 6.01% | 160.90% | – |
- DNTH's peers: ALMS (Alumis), ANAB (AnaptysBio), ARTV (Artiva Biotherapeutics), CNTB (Connect Biopharma), IMVT (Immunovant), MLTX (MoonLake), QTTB (Q32 Bio), RNAC (Cartesian Therapeutics).
Updated 2026-11-07 11:53 UTC